Find & Apply For Nuclear Medicine Technologist Jobs In Richland, South Carolina
Nuclear Medicine Technologist jobs in Richland, South Carolina involve preparing and administering radioactive drugs for imaging procedures, operating imaging equipment to capture images, and analyzing the results. These professionals also work closely with physicians to provide accurate diagnostic information for patient care. Below you can find different Nuclear Medicine Technologist positions in Richland, South Carolina.
Jobs in Richland
Browse jobs from a variety of sources below, sorted with the most recently published, nearest to the top. Click the title to view more information and apply online.
A South Carolina Facility Is Searching for a Locums Radiologist
Weatherby Healthcare
Richland, SC
Travel – Nuclear Medicine PET Techologist
Siemens Healthineers
Richland, SC
Travel Nuclear Med Tech Currently Needed in Columbia, SC: Travel in Safe Hands
Soliant Health
Richland, SC
Latest Jobs in Richland
Salary Information & Job Trends In this Region
Nuclear Medicine Technologists in Richland, South Carolina play a crucial role in diagnosing and treating patients using radioactive materials. - Entry-level Technologist salaries range from $50,000 to $60,000 per year - Mid-career Nuclear Medicine Technologist salaries range from $60,000 to $80,000 per year - Senior-level Radiopharmaceutical Specialist salaries range from $80,000 to $100,000 per year The history of Nuclear Medicine Technologists in Richland, South Carolina dates back to the mid-20th century when advancements in medical imaging led to the development of nuclear medicine as a specialized field. The evolution of Nuclear Medicine Technologists in Richland, South Carolina has seen significant technological advancements, such as PET-CT scans and SPECT imaging, improving diagnostic accuracy and patient outcomes. Current trends in Nuclear Medicine Technologists in Richland, South Carolina include the integration of artificial intelligence in image analysis, personalized treatment plans based on genetic markers, and the use of theranostics for targeted cancer therapy.
